Our effort was to enroll patients with normal concentrations of calcium, phosphate and PTH (according to their CKD stage) and no clinical or laboratory sign of inflammation, since in most clinical studies the beneficial effects of vitamin D on Hb levels were observed in patients with CKD with sustained levels of inflammation and elevated PTH values, considered as important cofactors of anemia. Here, GSTM1 is linked to anemia.